Roivant Sciences (ROIV) Stock Insights
$27.27B
Market Cap
-97.66
P/E
28.21
Forward P/E
35
Score
ROIV price $37.75 +0.64 +1.72%
Stocklytics score rationale: value 36, quality 30, growth 38.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 67689000 | 23795000 | 55286000 | 31530000 | 32713000 | 29053000 | 8260000 |
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as…
ROIV fair value $34.36. Price $37.75. Price is 10% above fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-09 | — | -0.37 | — | 3.74M |
| 2026-08-06 | -0.33 | -0.30 | 1.44M | 2.06M |
| 2026-05-20 | -0.28 | -0.29 | 2.52M | 3.41M |
| 2026-02-06 | -0.24 | -0.30 | 2.00M | 5.08M |
| 2025-11-10 | -0.20 | -0.32 | 1.57M | 5.62M |
| 2025-08-11 | -0.25 | -0.25 | 2.17M | 7.30M |
| 2025-05-29 | -0.29 | -0.26 | 7.57M | 54.07M |
| 2025-02-10 | -0.23 | -0.25 | 9.02M | 5.00M |
| 2024-11-12 | -0.29 | -0.25 | 4.47M | 45.92M |
| 2024-08-08 | 0.12 | -0.24 | 55.13M | 30.72M |
| 2024-05-30 | -0.23 | -0.26 | 28.93M | 31.01M |
| 2024-02-13 | -0.21 | -0.31 | 37.14M | 31.77M |
| 2023-11-13 | -0.26 | -0.28 | 37.10M | 27.11M |
| 2023-08-14 | -0.38 | -0.30 | 21.62M | 24.49M |
| 2023-06-28 | -0.20 | -0.41 | 27.38M | 18.17M |
| 2023-02-13 | -0.49 | -0.36 | 17.05M | 14.78M |
| 2022-11-14 | -0.42 | -0.41 | 12.53M | 5.70M |
| 2022-08-15 | -0.48 | -0.30 | 4.32M | 7.18M |
| 2022-06-28 | -0.39 | -0.25 | 9.22M | 13.35M |
| 2022-02-14 | -0.41 | -0.23 | 24.34M | 9.87M |
| 2021-11-15 | -0.26 | -0.45 | 13.99M | 7.22M |
| 2021-09-21 | — | — | — | — |
| 2021-08-10 | — | — | — | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-23 | Oren Ilan | Buy | 810 | — | — |
| 2026-10-23 | Epperly Melissa B, | Buy | 513 | — | — |
| 2026-10-23 | Epperly Melissa B, | Sell | 116 | $36.49 | 4.23K |
| 2026-10-23 | MOMTAZEE JAMES C | Buy | 383 | — | — |
| 2026-10-23 | MOMTAZEE JAMES C | Sell | 77 | $36.49 | 2.81K |
| 2026-10-20 | Venker Eric | Sell | 185.86K | $35.09 | 6.52M |
| 2026-10-20 | Venker Eric | Sell | 14.14K | $35.42 | 500.98K |
| 2026-10-16 | Sukhatme Mayukh | Sell | 19.98K | $33.53 | 669.80K |
| 2026-10-16 | Gline Matthew | Sell | 34.64K | $33.53 | 1.16M |
| 2026-10-01 | Epperly Melissa B, | Sell | 17.75K | $4.46 | 79.17K |
| 2026-10-01 | Epperly Melissa B, | Buy | 17.75K | $4.46 | 79.17K |
| 2026-10-01 | Epperly Melissa B, | Sell | 16.85K | $36.08 | 607.95K |
| 2026-10-01 | Epperly Melissa B, | Sell | 900 | $36.57 | 32.91K |
| 2026-09-30 | Gline Matthew | Sell | 76.17K | $36.57 | 2.79M |
| 2026-09-30 | Torti Frank | Buy | 40.31K | $36.57 | 1.47M |
| 2026-09-30 | Sukhatme Mayukh | Sell | 46.88K | $36.57 | 1.71M |
| 2026-09-30 | Venker Eric | Sell | 200.00K | $3.85 | 770.00K |
| 2026-09-30 | Venker Eric | Buy | 200.00K | $3.85 | 770.00K |
| 2026-09-30 | Venker Eric | Sell | 200.00K | $36.62 | 7.32M |
| 2026-09-20 | Humes Jennifer | Sell | 3.88K | $39.77 | 154.31K |
| 2026-09-20 | Pulik Richard | Sell | 2.13K | $39.77 | 84.67K |
| 2026-09-16 | MANCHESTER KEITH S | Buy | 5.05K | — | — |
| 2026-09-16 | MANCHESTER KEITH S | Buy | 10.53K | $39.57 | 416.71K |
| 2026-09-16 | Gold Daniel Allen | Buy | 5.05K | — | — |
| 2026-09-16 | Gold Daniel Allen | Buy | 10.53K | $39.57 | 416.71K |
| 2026-09-16 | Oren Ilan | Buy | 5.05K | — | — |
| 2026-09-16 | Oren Ilan | Buy | 10.53K | $39.57 | 416.71K |
| 2026-09-16 | MOMTAZEE JAMES C | Buy | 5.05K | — | — |
| 2026-09-16 | MOMTAZEE JAMES C | Buy | 10.53K | $39.57 | 416.71K |
| 2026-09-16 | Fitzgerald Meghan | Buy | 5.05K | — | — |
| 2026-09-16 | Fitzgerald Meghan | Buy | 10.53K | $39.57 | 416.71K |
| 2026-09-16 | Epperly Melissa B, | Buy | 5.05K | — | — |
| 2026-09-16 | Epperly Melissa B, | Buy | 10.53K | $39.57 | 416.71K |
| 2026-09-15 | Epperly Melissa B, | Sell | 4.34K | $39.65 | 172.00K |
| 2026-09-15 | Epperly Melissa B, | Sell | 600 | $40.38 | 24.23K |
| 2026-09-15 | Fitzgerald Meghan | Sell | 4.71K | $39.68 | 186.97K |
| 2026-09-15 | Fitzgerald Meghan | Sell | 400 | $40.45 | 16.18K |
| 2026-09-10 | Gold Daniel Allen | Sell | 5.13K | $40.94 | 210.15K |
| 2026-09-10 | Oren Ilan | Sell | 2.38K | $40.94 | 97.36K |
| 2026-09-10 | Epperly Melissa B, | Sell | 2.18K | $40.94 | 89.21K |
| 2026-09-10 | Fitzgerald Meghan | Sell | 1.74K | $40.94 | 71.36K |
| 2026-09-10 | MOMTAZEE JAMES C | Sell | 2.90K | $40.94 | 118.93K |
| 2026-09-08 | Fitzgerald Meghan | Buy | 20.00K | $8.80 | 176.00K |
| 2026-09-08 | Fitzgerald Meghan | Sell | 20.00K | $39.90 | 798.00K |
| 2026-09-08 | Fitzgerald Meghan | Sell | 20.00K | $8.80 | 176.00K |
| 2026-08-28 | Venker Eric | Sell | 200.00K | $3.85 | 770.00K |
| 2026-08-28 | Venker Eric | Buy | 200.00K | $3.85 | 770.00K |
| 2026-08-28 | Venker Eric | Sell | 166.18K | $35.63 | 5.92M |
| 2026-08-28 | Venker Eric | Sell | 33.82K | $36.44 | 1.23M |
| 2026-08-21 | Sukhatme Mayukh | Buy | 144.76K | $3.85 | 557.31K |
| 2026-08-21 | Sukhatme Mayukh | Sell | 144.76K | $36.48 | 5.28M |
| 2026-08-21 | Sukhatme Mayukh | Sell | 144.76K | $3.85 | 557.31K |
| 2026-08-20 | Pulik Richard | Sell | 5.75K | $36.84 | 211.79K |
| 2026-08-20 | Venker Eric | Sell | 13.91K | $36.84 | 512.41K |
| 2026-08-20 | Sukhatme Mayukh | Buy | 17.52K | $3.85 | 67.45K |
| 2026-08-20 | Sukhatme Mayukh | Sell | 17.52K | $37.30 | 653.46K |
| 2026-08-20 | Sukhatme Mayukh | Sell | 17.52K | $3.85 | 67.45K |
| 2026-08-19 | Sukhatme Mayukh | Buy | 172.90K | $3.85 | 665.66K |
| 2026-08-19 | Sukhatme Mayukh | Sell | 172.90K | $37.17 | 6.43M |
| 2026-08-19 | Sukhatme Mayukh | Sell | 172.90K | $3.85 | 665.66K |
| 2026-08-18 | Sukhatme Mayukh | Buy | 105.14K | $3.85 | 404.79K |
| 2026-08-18 | Sukhatme Mayukh | Buy | 31.80K | $3.85 | 122.43K |
| 2026-08-18 | Sukhatme Mayukh | Sell | 105.14K | $36.59 | 3.85M |
| 2026-08-18 | Sukhatme Mayukh | Sell | 31.80K | $37.18 | 1.18M |
| 2026-08-18 | Sukhatme Mayukh | Sell | 136.94K | $3.85 | 527.23K |
| 2026-08-17 | Sukhatme Mayukh | Buy | 284.71K | $3.85 | 1.10M |
| 2026-08-17 | Sukhatme Mayukh | Sell | 284.71K | $36.25 | 10.32M |
| 2026-08-17 | Sukhatme Mayukh | Sell | 284.71K | $3.85 | 1.10M |
| 2026-08-14 | Sukhatme Mayukh | Buy | 243.18K | $3.85 | 936.23K |
| 2026-08-14 | Sukhatme Mayukh | Sell | 243.18K | $36.23 | 8.81M |
| 2026-08-14 | Sukhatme Mayukh | Sell | 243.18K | $3.85 | 936.23K |
| 2026-07-27 | Venker Eric | Sell | 200.00K | $3.85 | 770.00K |
| 2026-07-27 | Venker Eric | Buy | 200.00K | $3.85 | 770.00K |
| 2026-07-27 | Venker Eric | Sell | 200.00K | $34.95 | 6.99M |
| 2026-07-17 | MOMTAZEE JAMES C | Buy | 405 | — | — |
| 2026-07-17 | Epperly Melissa B, | Buy | 543 | — | — |
| 2026-07-17 | Oren Ilan | Buy | 775 | — | — |
| 2026-06-30 | Gline Matthew | Sell | 76.17K | $35.39 | 2.70M |
| 2026-06-30 | Fitzgerald Meghan | Buy | 10.00K | $8.80 | 88.00K |
| 2026-06-30 | Fitzgerald Meghan | Sell | 10.00K | $34.90 | 349.00K |
| 2026-06-30 | Fitzgerald Meghan | Sell | 10.00K | $8.80 | 88.00K |
| 2026-06-30 | Torti Frank | Sell | 40.31K | $35.39 | 1.43M |
| 2026-06-30 | Sukhatme Mayukh | Sell | 46.88K | $35.39 | 1.66M |
| 2026-06-30 | MANCHESTER KEITH S | Sell | 12.38K | $35.28 | 436.77K |
| 2026-06-30 | MANCHESTER KEITH S | Sell | 200.00K | $35.45 | 7.09M |
| 2026-06-30 | Gold Daniel Allen | Sell | 12.38K | $35.28 | 436.77K |
| 2026-06-30 | QVT Financial LP | Sell | 12.38K | $35.28 | 436.77K |
| 2026-06-29 | Epperly Melissa B, | Sell | 17.75K | $4.46 | 79.17K |
| 2026-06-29 | Epperly Melissa B, | Buy | 17.75K | $4.46 | 79.17K |
| 2026-06-29 | Epperly Melissa B, | Sell | 15.00K | $34.32 | 514.87K |
| 2026-06-29 | Epperly Melissa B, | Sell | 2.75K | $34.71 | 95.38K |
| 2026-06-29 | MANCHESTER KEITH S | Sell | 200.00K | $34.44 | 6.89M |
| 2026-06-29 | MANCHESTER KEITH S | Sell | 600.00K | $34.59 | 20.75M |
| 2026-06-29 | Gold Daniel Allen | Sell | 200.00K | $34.44 | 6.89M |
| 2026-06-29 | Gold Daniel Allen | Sell | 600.00K | $34.59 | 20.75M |
| 2026-06-29 | QVT Financial LP | Sell | 200.00K | $34.44 | 6.89M |
| 2026-06-29 | QVT Financial LP | Sell | 600.00K | $34.59 | 20.75M |
| 2026-06-26 | MANCHESTER KEITH S | Sell | 300.78K | $33.92 | 10.20M |
| 2026-06-26 | MANCHESTER KEITH S | Sell | 325.00K | $34.07 | 11.07M |
| 2026-06-26 | Gold Daniel Allen | Sell | 300.78K | $33.92 | 10.20M |
Latest filed quarter: Q2 2026.
Institutions holding: 519, holders +51 vs prior quarter. Ownership 77.77%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| FMR LLC | 81.02M | 3.04M | +3.90% | 2.87B |
| BLACKROCK, INC. | 48.24M | 3.98M | +9.00% | 1.71B |
| MORGAN STANLEY | 42.59M | -9.24M | -17.82% | 1.51B |
| QVT FINANCIAL LP | 23.72M | -1.44M | -5.72% | 839.56M |
| VANGUARD CAPITAL MANAGEMENT LLC | 22.12M | 1.44M | +6.98% | 782.94M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 21.64M | 1.80M | +9.09% | 765.89M |
| GOLDMAN SACHS GROUP INC | 18.56M | 7.44M | +67.00% | 656.71M |
| STATE STREET CORP | 17.80M | 1.61M | +9.94% | 629.80M |
| UBS GROUP AG | 17.47M | -5.15M | -22.78% | 618.14M |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 14.31M | 4.63M | +47.90% | 506.40M |
| GEODE CAPITAL MANAGEMENT, LLC | 11.67M | 1.49M | +14.65% | 425.54M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 10.35M | -2.44M | -19.11% | 366.26M |
| WELLS FARGO & COMPANY/MN | 9.60M | 9.60M | New | 339.74M |
| TWO SEAS CAPITAL LP | 8.48M | 7.74M | +1057.36% | 299.94M |
| ASSENAGON ASSET MANAGEMENT S.A. | 8.36M | 1.29M | +18.18% | 295.96M |
| PERCEPTIVE ADVISORS LLC | 8.09M | -200.00K | -2.41% | 286.14M |
| PATIENT SQUARE CAPITAL LP | 8.02M | -145.12K | -1.78% | 283.86M |
| INVESCO LTD. | 7.53M | 1.09M | +16.96% | 266.53M |
| JANE STREET GROUP, LLC | 7.29M | 6.26M | +613.76% | 257.83M |
| DARWIN GLOBAL MANAGEMENT, LTD. | 6.75M | -50.00K | -0.74% | 234.33M |
| AQR CAPITAL MANAGEMENT LLC | 6.63M | 686.70K | +11.55% | 234.03M |
| VIKING GLOBAL INVESTORS LP | 6.27M | -380.98K | -5.73% | 221.95M |
| RUBRIC CAPITAL MANAGEMENT LP | 6.00M | 1.00M | +20.00% | 212.34M |
| CITADEL ADVISORS LLC | 5.58M | 3.06M | +121.63% | 197.34M |
| DIMENSIONAL FUND ADVISORS LP | 5.23M | -2.25M | -30.04% | 185.06M |
Insights · Dividends · Forecast · Financials · Learn
$27.27B
Market Cap
-97.66
P/E
28.21
Forward P/E
35
Score